Clinical systems · Inpatient insulin management software
Glytec
Glytec is a glycemic management software company whose FDA-cleared Glucommander tool calculates insulin doses for hospital patients inside the EHR, used by more than 400 hospitals to cut low blood sugar events and track glucose safety across a health system.
Strong fit
- Hospitals and health systems that still dose IV or subcutaneous insulin from paper or EHR order-set protocols
- Quality and pharmacy leaders preparing for the CMS severe hypoglycemia and hyperglycemia measures
- Systems on Epic or another major EHR that want dosing advice inside the nurse workflow
Weak fit
- Outpatient clinics and practices, since the product is built for inpatient insulin
- Small hospitals that see few patients on insulin drips
- Buyers who want a public price list before a sales call
Bottom line
Glytec gives hospital nurses and doctors FDA-cleared insulin dosing advice inside the EHR, plus a command center that shows glucose risk across every unit. It is worth a close look for any health system that wants fewer hypoglycemia events and has to report the new CMS glucose harm measures. Nurses still do the frequent glucose checks, and physicians still own the overall insulin plan.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Glytec is used by hospitals and health systems for patients who need insulin during a stay, from intensive care patients on IV insulin drips to people with diabetes on subcutaneous doses after surgery. Nurses enter each glucose reading, and Glucommander, the company's FDA-cleared dosing software, recommends the next dose and when to check again. The wider GlytecOne platform, described on the Glytec homepage, adds a Command Center for watching glucose risk across units, decision support, performance analytics, and population health reporting. Glucommander is cleared for adults and for children aged 2 to 17.
Glytec says it has more than 400 hospital clients, more than 100 patents, and more than 50 billion data points. Company-published results include a reduction in inpatient hypoglycemia of up to 99.8%, up to 68% fewer 30-day readmissions, and a return of 6 to 8 times the cost. A Riverside Healthcare case study reports savings of more than $2.6 million a year. These are vendor figures, and results vary with how fully a hospital adopts the protocols.
On price, Glytec is priced like enterprise hospital software, sold per system through a sales process. Its main commercial competitor is EndoTool from Monarch Medical Technologies, and its most common real alternatives are paper insulin protocols and the calculators built into EHR order sets. Healthcare Industry Reviews has not reviewed another inpatient insulin dosing vendor, so there is no competitor chart on this page.
The company traces its first FDA clearance to 2006, according to its company history. It was founded by software developer Robby Booth and diabetologist Dr. Bruce Bode, and is led by CEO Patrick Cua. Glytec does not publish revenue. Its revenue is an estimated $50 million a year, based on third-party employee and revenue estimates and its count of more than 400 hospital clients.
Demand is rising because CMS now requires hospitals to report severe hypoglycemia and severe hyperglycemia as hospital harm electronic clinical quality measures, with the 2026 measurement period starting January 1, 2026. Cua told Digital Times that "Insulin is one of the most common high-risk medications in the hospital." The limits are on the floor. Nurses on allnurses describe the hourly fingersticks on an insulin drip as the tiring part, and physicians still have to manage the overall insulin plan.
What nurses and buyers say
What people like
"While everyone does complain about it, it is just the pain in the behind of having such frequent blood glucose checks that gets tedious, not the program itself. I find the program very easy to use." allnurses
"The drip rate changes with every reading, so I am not paging the resident at 3 AM to ask what to do with a sugar of 240."
What people don't like
"It isn't overly friendly. The docs still need to manage the overall dose of insulin." allnurses
"Hourly fingersticks on every drip patient add up on a busy unit, and the software does not change that part of the job."
Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums, and product documentation.
Based on: allnurses thread on Glucommander, Glytec homepage, and Riverside Healthcare case study.
Pricing
| Item | Detail |
|---|---|
| Model | Enterprise software contract for a hospital or health system, priced through a sales process. |
| What usually drives cost | The number of hospitals and beds covered, which GlytecOne modules are included, and EHR integration work. |
| What to ask before you buy | Ask which EHR integration is included, who trains the nurses, and whether Command Center reports line up with the CMS glucose harm measures. |
| Note | Glucommander recommends doses. Clinicians still order insulin and own the care plan. |
Leadership
Patrick CuaChief Executive Officer- Robby BoothCo-founder; Chief Product and Regulatory Officer
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.